JESSICA DONOHUE: Open Payments
NPI 1386324689 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 65 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $146 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $369 |
| Vanda Pharmaceuticals Inc. | 7 | $229 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Alkermes, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Lundbeck LLC | 2 | $49 |
| Almatica Pharma LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
Products named: VRAYLAR, FANAPT, ARISTADA, Auvelity, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI, SPRAVATO.
Industry payments across FL — which companies pay providers there.
